Treatment of central nervous system metastases: parenchymal, epidural, and leptomeningeal.
OBJECTIVE
With prolonged survival from systemic therapies in the adjuvant and salvage setting, and because these agents cannot cross the intact blood-brain barrier, central nervous system metastases are becoming a therapeutic challenge in oncology.


RESULTS
Recent therapeutic achievements include an extended use of surgery and radiosurgery. Although each of these treatment modalities has its own indications, in patients eligible for both treatments the upfront comparison of these two techniques has not been performed yet. Systemic chemotherapies and biotherapies may be effective in the management of central nervous system metastases as they may act on both neurologic and extra-central nervous system lesions. In the treatment of epidural metastases, a surgical procedure providing immediate direct circumferential decompression of the spinal cord followed by local irradiation has been demonstrated in a prospective randomized trial. The management of leptomeningeal metastases remains controversial and of limited efficacy especially in chemoresistant tumours and still relies on the combination of chemotherapy (intrathecal and intravenous) and focal radiotherapy.


CONCLUSIONS
Aggressive treatments in patients with early diagnosis and in whom central nervous system metastases are the life-threatening location may provide a substantial increase in survival and favourably affect quality of life.
Taillibert
Sophie
S
Neurology Department Mazarin, Hôpital Salpétrière, Paris, France. sophie.taillibert@psl.aphp.fr
Hildebrand
Jerzy
J
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000556:secondary / Q000628:therapy*; D003131:Combined Modality Therapy; D015174:Epidural Neoplasms / Q000556:secondary / Q000628:therapy*; D006801:Humans; D008577:Meningeal Neoplasms / Q000556:secondary / Q000628:therapy*; D011878:Radiotherapy
D000970:Antineoplastic Agents